Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TYO/4886 stock hub

TYO/4886 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TYO/4886is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
83.3B
Tokyo Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TYO/4886
In the news

Latest news · TYO/4886

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.1
P25 12.7P50 15.8P75 21.7
Trailing P/E17
P25 11.7P50 15.2P75 22.3
ROE7.2
P25 -1.6P50 7.1P75 11.9
ROIC5.9
P25 -0.6P50 6.2P75 14.3
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TYO/4886 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
212
Groups with data
11
Currency
JPY
Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Japan
Country code
JP
Employees
1,632
Employees Change
870%
Employees Change Percent
114.2
Enterprise value
JPY 96.4B
Exchange
Tokyo Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
JP3119660003
Last refreshed
2026-05-10
Market cap
JPY 83.3B
Price
JPY 2,933
Price currency
JPY
Rev Per Employee
42,094,975.49x
Sector
Healthcare
Sic
2834
Symbol
tyo/4886
Website
https://www.aska-pharma-hd.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
5.89%
EV Earnings
19.65x
EV/EBIT
21.01x
EV/EBITDA
14.78x
EV/Sales
1.4x
Forward P/E
15.11x
P/B ratio
1.11x
P/E ratio
16.96x
P/S ratio
1.21x
PE Ratio10 Y
19.26x
PE Ratio3 Y
10.4x
PE Ratio5 Y
9.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
Gross Profit
JPY 33.2B
Gross Profit Growth
5.44%
Gross Profit Growth Q
9.24%
Gross Profit Growth3 Y
5.82%
Gross Profit Growth5 Y
5.19%
Net Income
JPY 4.9B
Net Income Growth
-5.36%
Net Income Growth Q
9.1%
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Net Income Growth3 Y
3.77%
Net Income Growth5 Y
19.24%
Pretax Margin
8.29%
Profit Per Employee
JPY 3M
Profitable Years
14
ROA
2.91
Roa5y
3.64
ROCE
5.43
ROE
7.19
Roe5y
8.88
ROIC
5.95
Roic5y
7.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr10y
9.6%
Cagr15y
12.03%
Cagr1y
30.22%
Cagr20y
6.6%
Cagr3y
34.46%
Cagr5y
19.01%
Div CAGR10
14.66%
Div CAGR3
50.92%
Div CAGR5
31.48%
EPS Growth
-5.48
EPS Growth Q
8.98
EPS Growth Quarters
1
EPS Growth Years
0
EPS Growth3 Y
3.61
EPS Growth5 Y
19.21
Revenue Growth
7.44x
Revenue Growth Q
9.56x
Revenue Growth Quarters
16x
Revenue Growth Years
6x
Revenue Growth3 Y
4.8x
Revenue Growth5 Y
4.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
JPY 0.67
Assets
JPY 112.7B
Cash
JPY 6.6B
Current Assets
JPY 60.7B
Current Liabilities
JPY 25.3B
Debt
JPY 13.7B
Debt Equity
JPY 0.18
Equity
JPY 74.7B
Interest Coverage
26.68
Liabilities
JPY 38B
Long Term Assets
JPY 52B
Long Term Liabilities
JPY 12.7B
Net Cash
JPY -7.1B
Net Cash By Market Cap
JPY -8.56
Net Debt EBITDA
JPY 1.07
Net Debt Equity
JPY 0.1
Tangible Book Value
JPY 59.9B
Tangible Book Value Per Share
JPY 2,110
WACC
5.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.4
Inventory Turnover
1.37
Net Working Capital
JPY 33.9B
Quick ratio
1.06
Working Capital
JPY 35.4B
Working Capital Turnover
JPY 2.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-0.11%
Dividend Growth
0%
Dividend Growth Years
3%
Dividend per share
JPY 55
Dividend Years
35
Dividend Yield
1.88%
Ex Div Date
2026-03-30
Last Dividend
JPY 28
Payout Frequency
Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
150.07%
1Y total return
30.2%
200-day SMA
2,319.4
3Y total return
143.14%
50-day SMA
2,553.7
50-day SMA vs 200-day SMA
50over200
5Y total return
138.68%
All Time High
3,020
All Time High Change
-2.88%
All Time High Date
2026-04-16
All Time Low
401
All Time Low Change
631.42%
All Time Low Date
2012-10-11
ATR
95.78
Beta
0.4
Beta1y
0.6
Beta2y
0.6
Ch YTD
43.92
High
2,941
High52
3,020
High52 Date
2026-04-16
High52ch
-2.88%
Low
2,770
Low52
1,920
Low52 Date
2025-12-15
Low52ch
52.76%
Ma50ch
14.85%
Price vs 200-day SMA
26.45%
RSI
61.61
RSI Monthly
69.35
RSI Weekly
68.62
Sharpe ratio
0.72x
Sortino ratio
1.39
Total Return
1.76%
Tr YTD
45.64
Tr15y
449.75%
Tr1m
9.65%
Tr1w
1.31%
Tr3m
23.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
JPY 4.7B
Operating Income Growth
-26.6
Operating Income Growth Q
5.21
Operating Income Growth3 Y
-2.74
Operating Income Growth5 Y
4.76
Operating margin
6.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
20,048,525%
Shares Insiders
2.83%
Shares Institutions
27.82%
Shares Out
28,396,125
Shares Qo Q
0.05%
Shares Yo Y
0.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Average Volume
124,155x
Bv Per Share
2,420.6
Ch10y
114.7
Ch15y
332
Ch1m
9.65
Ch1w
1.31
Ch1y
27.19
Ch20y
158.4
Ch3m
22.21
Ch3y
127.2
Ch5y
115.7
Ch6m
43.63
Change
1.88%
Change From Open
3.24
Close
2,879
Days Gap
-1.32
Depreciation Amortization
1,935,750,000
Dollar Volume
464,000,600
Earnings Date
2026-05-15
EBIT
JPY 4.7B
EBITDA
JPY 6.7B
EPS
JPY 173
F Score
2
Fiscal Year End
March
Founded
1,920
Goodwill
2,252,000,000
Graham Number
3068.99923
Graham Upside
4.64
Income Tax
JPY 665M
Is Primary Listing
1
Last Earnings Date
2026-02-02
Last Report Date
2025-12-31
Lynch Fair Value
JPY 3,327
Lynch Upside
13.42
Ma150
2,283.5
Ma150ch
28.45%
Ma20
2,845.1
Ma20ch
3.09%
Next Earnings Date
2026-05-15
Open
2,841
Payment Date
2026-06-25
Position In Range
95.32
Ppne
19,075,000,000
Price Date
2026-05-08
Price EBITDA
JPY 12.46
Ptbv Ratio
1.39
Relative Volume
1.27x
Revenue
68,699,000,000x
Tax By Revenue
0.97x
Tr20y
259.2%
Tr6m
45.35%
Volume
158,200
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TYO/4886 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.9%
$55.0 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+31.5%
3 consecutive years of growth
Total shareholder yield
+1.8%
Next ex-dividend date: 2026-03-30
Performance

TYO/4886 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+30.2%
S&P 500 1Y: n/a
3Y total return
+143.1%
S&P 500 3Y: n/a
5Y total return
+138.7%
S&P 500 5Y: n/a
10Y total return
+150.1%
S&P 500 10Y: n/a
Ownership

Who owns TYO/4886?

Insider, institutional, and short-interest positioning.

Institutional ownership
+27.8%
Share of float held by funds and institutions
Insider ownership
+2.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

TYO/4886 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
61.6
Neutral momentum band
Price vs 200-day MA
+26.5%
50/200-day relationship not available
Beta (5Y)
0.40
Less volatile than the market
Sharpe ratio
0.72
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TYO/4886

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4886 stock rating?

tyo/4886 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4886 analysis?

The full report lives at /stocks/tyo/4886/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4886?

The latest report frames tyo/4886 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4886 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.